Cite
Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.
MLA
Guisado-Vasco, Pablo, et al. “Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.” Journal of Infectious Diseases, vol. 226, no. 1, July 2022, pp. 1–5. EBSCOhost, https://doi.org/10.1093/infdis/jiac090.
APA
Guisado-Vasco, P., Gorines, J. A., González, M. M. C., Fernández, G. S., & Ruiz, D. C. (2022). Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019. Journal of Infectious Diseases, 226(1), 1–5. https://doi.org/10.1093/infdis/jiac090
Chicago
Guisado-Vasco, Pablo, José Aguarles Gorines, María M Carralón González, Gabriel Sotres Fernández, and Daniel Carnevali Ruiz. 2022. “Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.” Journal of Infectious Diseases 226 (1): 1–5. doi:10.1093/infdis/jiac090.